Voya Investment Management LLC Affimed N.V. Transaction History

Voya Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.32 $12,124 - $20,537	6,186 Added 11.69%	59,093 $122,000
Q2 2022 Aug 15, 2022	BUY	$2.27 - $4.86 $16,071 - $34,408	7,080 Added 15.45%	52,907 $147,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $7.07 $3,232 - $4,256	-602 Reduced 1.3%	45,827 $253,000
Q2 2021 Aug 16, 2021	SELL	$7.78 - $11.4 $13,615 - $19,950	-1,750 Reduced 3.63%	46,429 $395,000
Q1 2021 May 17, 2021	BUY	$5.12 - $8.48 $54,123 - $89,642	10,571 Added 28.11%	48,179 $381,000
Q4 2020 Feb 16, 2021	BUY	$3.16 - $7.03 $38,198 - $84,978	12,088 Added 47.37%	37,608 $219,000
Q2 2020 Aug 14, 2020	SELL	$1.58 - $4.63 $13,392 - $39,243	-8,476 Reduced 24.93%	25,520 $118,000
Q4 2019 Feb 14, 2020	BUY	$2.25 - $3.07 $22,639 - $30,890	10,062 Added 42.04%	33,996 $93,000
Q2 2019 Aug 14, 2019	BUY	$2.6 - $4.21 $62,228 - $100,762	23,934 New	23,934 $69,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $520M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.